Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In Vivo

Background: Inefficient cellular uptake is a significant limitation to the efficacy of DNA vaccines. In this study, we introduce S-Cr9T, a stearyl-modified cell-penetrating peptide (CPP) designed to enhance DNA vaccine delivery by forming stable complexes with plasmid DNA, thereby protecting it from...

Full description

Saved in:
Bibliographic Details
Main Authors: Sheng Jiang, Cheng Zu, Bin Wang, Yiwei Zhong
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/1/94
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587342691434496
author Sheng Jiang
Cheng Zu
Bin Wang
Yiwei Zhong
author_facet Sheng Jiang
Cheng Zu
Bin Wang
Yiwei Zhong
author_sort Sheng Jiang
collection DOAJ
description Background: Inefficient cellular uptake is a significant limitation to the efficacy of DNA vaccines. In this study, we introduce S-Cr9T, a stearyl-modified cell-penetrating peptide (CPP) designed to enhance DNA vaccine delivery by forming stable complexes with plasmid DNA, thereby protecting it from degradation and promoting efficient intracellular uptake. Methods and Results: In vitro studies showed that S-Cr9T significantly improved plasmid stability and transfection efficiency, with optimal performance at an N/P ratio of 0.25. High-content imaging revealed that the S-Cr9T–plasmid complex stably adhered to the cell membrane, leading to enhanced plasmid uptake and transfection. In vivo, S-Cr9T significantly increased antigen expression and triggered a robust immune response, including a threefold increase in IFN-γ secretion and several hundred-fold increases in antibody levels compared to control groups. Conclusions: These findings underscore the potential of S-Cr9T to enhance DNA vaccine efficacy, offering a promising platform for advanced gene therapy and vaccination strategies.
format Article
id doaj-art-30c95223428a40319edc2ec1bb2cf406
institution Kabale University
issn 2076-393X
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj-art-30c95223428a40319edc2ec1bb2cf4062025-01-24T13:51:55ZengMDPI AGVaccines2076-393X2025-01-011319410.3390/vaccines13010094Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In VivoSheng Jiang0Cheng Zu1Bin Wang2Yiwei Zhong3Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, ChinaShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, ChinaShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, ChinaShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, ChinaBackground: Inefficient cellular uptake is a significant limitation to the efficacy of DNA vaccines. In this study, we introduce S-Cr9T, a stearyl-modified cell-penetrating peptide (CPP) designed to enhance DNA vaccine delivery by forming stable complexes with plasmid DNA, thereby protecting it from degradation and promoting efficient intracellular uptake. Methods and Results: In vitro studies showed that S-Cr9T significantly improved plasmid stability and transfection efficiency, with optimal performance at an N/P ratio of 0.25. High-content imaging revealed that the S-Cr9T–plasmid complex stably adhered to the cell membrane, leading to enhanced plasmid uptake and transfection. In vivo, S-Cr9T significantly increased antigen expression and triggered a robust immune response, including a threefold increase in IFN-γ secretion and several hundred-fold increases in antibody levels compared to control groups. Conclusions: These findings underscore the potential of S-Cr9T to enhance DNA vaccine efficacy, offering a promising platform for advanced gene therapy and vaccination strategies.https://www.mdpi.com/2076-393X/13/1/94DNA vaccinecell-penetrating peptidein vitro expressionin vivo expressionantibody responseT cell response
spellingShingle Sheng Jiang
Cheng Zu
Bin Wang
Yiwei Zhong
Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In Vivo
Vaccines
DNA vaccine
cell-penetrating peptide
in vitro expression
in vivo expression
antibody response
T cell response
title Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In Vivo
title_full Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In Vivo
title_fullStr Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In Vivo
title_full_unstemmed Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In Vivo
title_short Enhancing DNA Vaccine Delivery Through Stearyl-Modified Cell-Penetrating Peptides: Improved Antigen Expression and Immune Response In Vitro and In Vivo
title_sort enhancing dna vaccine delivery through stearyl modified cell penetrating peptides improved antigen expression and immune response in vitro and in vivo
topic DNA vaccine
cell-penetrating peptide
in vitro expression
in vivo expression
antibody response
T cell response
url https://www.mdpi.com/2076-393X/13/1/94
work_keys_str_mv AT shengjiang enhancingdnavaccinedeliverythroughstearylmodifiedcellpenetratingpeptidesimprovedantigenexpressionandimmuneresponseinvitroandinvivo
AT chengzu enhancingdnavaccinedeliverythroughstearylmodifiedcellpenetratingpeptidesimprovedantigenexpressionandimmuneresponseinvitroandinvivo
AT binwang enhancingdnavaccinedeliverythroughstearylmodifiedcellpenetratingpeptidesimprovedantigenexpressionandimmuneresponseinvitroandinvivo
AT yiweizhong enhancingdnavaccinedeliverythroughstearylmodifiedcellpenetratingpeptidesimprovedantigenexpressionandimmuneresponseinvitroandinvivo